Fraunhofer Institute for Toxicology and Experimental Medicine

Gentle treatment for premature babies

Researchers at Fraunhofer ITEM are working on an intelligent inhalation system for babies with lung diseases.

more info

Australian researchers explored the German healthcare sector

On November 8, 2018, 16 Australian researchers visited Fraunhofer ITEM as part of the InnoTour 2018.

more info

MDR – handicap for the innovation hotspot Germany

High-Performance Center Translational Biomedical Engineering is suggesting specific measures for a revision of the Medical Device Regulation.

more info

Chip-based cell analysis by chip cytometry

New technology at Fraunhofer ITEM enables sputum analysis by chip cytometry.

more info

Project EU-ToxRisk

Fraunhofer ITEM scientists will test new approach methodologies for animal-free toxicity testing and risk assessment

more info

Fraunhofer ITEM: News

News / 31.1.2019

Sustainable chemicals policy

Dr. Oliver Licht has been appointed to a working group of the 8th Lower Saxony Governmental Commission on sustainable environmental policy and digital change.

News / 18.1.2019

Publication: Rating sputum cell quality

Development of a more comprehensive form of sputum evaluation to improve data quality in clinical trials.

Press Release / 10.12.2018

Gentle treatment for premature babies

Researchers at Fraunhofer ITEM are working on an intelligent inhalation system for babies with lung diseases. 

Events / 10.12.2018

Models of Lung Disease

Registration is open and a preliminary program is available! Innovative topics and impulses from translational lung research will be at the focus at the CRC Hannover on January 24 and 25.

 

Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0

Events

2.4.2019

Training course: In-silico toxicology

This training course will introduce the participants to three different in-silico approaches for estimation of human health toxicological endpoints, namely QSAR models, read-across, and the TTC (threshold of toxicological concern) concept. The application of in-silico approaches in ecotoxicology will not be addressed in this course.
Read more

10.3.2019

SOT 2019

At this year’s Annual Meeting of the Society of Toxicology, we will present our recent research on toxicological issues in numerous sessions and posters.
Read more

25.2.2019

DGPT 2019

Fraunhofer ITEM scientists will present recent research work at the 4th German Pharm-Tox Summit in Stuttgart (Germany) from February 25 to 28.
Read more

24.1.2019

18th Fraunhofer Seminar "Models of Lung Disease"

On January 24 and 25, 2019, the 18th Fraunhofer Seminar "Models of Lung Disease" will take place at the CRC Hannover. Online registration is open and a preliminary program is available.
Read more

Our services and expertise

 

Drug Development

From drug candidate to proof of concept

 

Chemical Safety and Assessment

From risk analysis towards safe products

 

Translational Biomedical Engineering

From idea to safe medical device

 

Personalized Tumor Therapy

From molecular analysis to personalized therapy

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of approximately 70 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on airway research, our R&D portfolio includes three thematic areas: drug development, chemical safety, and translational biomedical engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

With a staff of approximately 300 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.

More information about Fraunhofer ITEM